
Jonathan P. Ouellette
Examiner (ID: 7976, Phone: (571)272-6807 , Office: P/3629 )
| Most Active Art Unit | 3629 |
| Art Unit(s) | 3629 |
| Total Applications | 1485 |
| Issued Applications | 848 |
| Pending Applications | 146 |
| Abandoned Applications | 509 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18374322
[patent_doc_number] => 20230149401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => FURIN INHIBITORS FOR TREATING CORONAVIRUS INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/915878
[patent_app_country] => US
[patent_app_date] => 2021-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30781
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915878
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/915878 | FURIN INHIBITORS FOR TREATING CORONAVIRUS INFECTIONS | Mar 31, 2021 | Abandoned |
Array
(
[id] => 18251663
[patent_doc_number] => 20230078702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME FOR TREATING BREAST CANCER
[patent_app_type] => utility
[patent_app_number] => 17/760240
[patent_app_country] => US
[patent_app_date] => 2021-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4785
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17760240
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/760240 | USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME FOR TREATING BREAST CANCER | Feb 8, 2021 | Pending |
Array
(
[id] => 18374335
[patent_doc_number] => 20230149414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/795747
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 129753
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17795747
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/795747 | COMPOUNDS AND USES THEREOF | Jan 28, 2021 | Pending |
Array
(
[id] => 18241188
[patent_doc_number] => 20230073499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => COMPOUNDS FOR USE IN THE TREATMENT OF LEUKEMIA
[patent_app_type] => utility
[patent_app_number] => 17/759546
[patent_app_country] => US
[patent_app_date] => 2021-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7972
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17759546
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/759546 | COMPOUNDS FOR USE IN THE TREATMENT OF LEUKEMIA | Jan 27, 2021 | Pending |
Array
(
[id] => 18215184
[patent_doc_number] => 11590096
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Compositions for prevention or treatment of acute radiation syndrome and other radiation exposure
[patent_app_type] => utility
[patent_app_number] => 17/114473
[patent_app_country] => US
[patent_app_date] => 2020-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 88
[patent_figures_cnt] => 134
[patent_no_of_words] => 30576
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17114473
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/114473 | Compositions for prevention or treatment of acute radiation syndrome and other radiation exposure | Dec 6, 2020 | Issued |
Array
(
[id] => 18158657
[patent_doc_number] => 20230025249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => PROCESS FOR THE PREPARATION OF 5-CHLORO-PYRIDINE-2-CARBOXYLIC ACIDS AND CARBOXYLATES WITH 3-SULFUR CONTAINING SUBSTITUENTS
[patent_app_type] => utility
[patent_app_number] => 17/779854
[patent_app_country] => US
[patent_app_date] => 2020-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3287
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17779854
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/779854 | PROCESS FOR THE PREPARATION OF 5-CHLORO-PYRIDINE-2-CARBOXYLIC ACIDS AND CARBOXYLATES WITH 3-SULFUR CONTAINING SUBSTITUENTS | Nov 26, 2020 | Pending |
Array
(
[id] => 17399556
[patent_doc_number] => 20220041646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => METHOD FOR PREPARING ORYZANOL FROM ORYZANOL-CONTAINING SOAPSTOCK SERVING AS RAW MATERIAL
[patent_app_type] => utility
[patent_app_number] => 17/310122
[patent_app_country] => US
[patent_app_date] => 2020-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7996
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 225
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17310122
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/310122 | METHOD FOR PREPARING ORYZANOL FROM ORYZANOL-CONTAINING SOAPSTOCK SERVING AS RAW MATERIAL | Nov 16, 2020 | Abandoned |
Array
(
[id] => 18091302
[patent_doc_number] => 20220409643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => ROR Gamma T Inhibitors and Topical Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/772815
[patent_app_country] => US
[patent_app_date] => 2020-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15142
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17772815
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/772815 | ROR Gamma T Inhibitors and Topical Uses Thereof | Nov 4, 2020 | Abandoned |
Array
(
[id] => 17981146
[patent_doc_number] => 20220347182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => METHODS AND COMPOSITIONS FOR THE TREATMENT OF OSTEOARTHRITIS
[patent_app_type] => utility
[patent_app_number] => 17/765086
[patent_app_country] => US
[patent_app_date] => 2020-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22572
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17765086
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/765086 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF OSTEOARTHRITIS | Oct 1, 2020 | Abandoned |
Array
(
[id] => 16710235
[patent_doc_number] => 20210077382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => COMPOSITIONS, DEVICES, AND METHODS FOR THE TREATMENT OF OPIOID-RECEPTOR-MEDIATED CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/024149
[patent_app_country] => US
[patent_app_date] => 2020-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26498
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17024149
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/024149 | COMPOSITIONS, DEVICES, AND METHODS FOR THE TREATMENT OF OPIOID-RECEPTOR-MEDIATED CONDITIONS | Sep 16, 2020 | Abandoned |
Array
(
[id] => 16435628
[patent_doc_number] => 20200352953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING AN INFECTION
[patent_app_type] => utility
[patent_app_number] => 16/938247
[patent_app_country] => US
[patent_app_date] => 2020-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32422
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16938247
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/938247 | COMPOSITIONS AND METHODS FOR TREATING AN INFECTION | Jul 23, 2020 | Abandoned |
Array
(
[id] => 16555675
[patent_doc_number] => 20210000823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => METHODS OF TREATING HIV
[patent_app_type] => utility
[patent_app_number] => 16/919677
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16919677
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/919677 | METHODS OF TREATING HIV | Jul 1, 2020 | Abandoned |
Array
(
[id] => 18091432
[patent_doc_number] => 20220409773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => TRANSPLANTATION DEVICE USING CHEMICALLY CROSSLINKED ALGINIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/620918
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34597
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17620918
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/620918 | TRANSPLANTATION DEVICE USING CHEMICALLY CROSSLINKED ALGINIC ACID | Jun 25, 2020 | Pending |
Array
(
[id] => 18057869
[patent_doc_number] => 20220388955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => EP2 ANTAGONIST
[patent_app_type] => utility
[patent_app_number] => 17/621137
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32964
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17621137
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/621137 | EP2 ANTAGONIST | Jun 25, 2020 | Pending |
Array
(
[id] => 16359238
[patent_doc_number] => 20200315989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => COMPOSITION COMPRISING FARNESOL AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/910392
[patent_app_country] => US
[patent_app_date] => 2020-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15494
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16910392
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/910392 | COMPOSITION COMPRISING FARNESOL AND USE THEREOF | Jun 23, 2020 | Abandoned |
Array
(
[id] => 18434355
[patent_doc_number] => 20230181649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => EXOSOMES FOR DISEASE TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/596827
[patent_app_country] => US
[patent_app_date] => 2020-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24737
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17596827
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/596827 | EXOSOMES FOR DISEASE TREATMENT | Jun 18, 2020 | Pending |
Array
(
[id] => 16621485
[patent_doc_number] => 20210040138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => OXYSTEROLS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/902730
[patent_app_country] => US
[patent_app_date] => 2020-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19310
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16902730
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/902730 | OXYSTEROLS AND METHODS OF USE THEREOF | Jun 15, 2020 | Abandoned |
Array
(
[id] => 18656086
[patent_doc_number] => 20230301957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => POLYGLYCEROL FATTY ACID ESTER COMPOSITION AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/007529
[patent_app_country] => US
[patent_app_date] => 2020-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4570
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007529
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/007529 | POLYGLYCEROL FATTY ACID ESTER COMPOSITION AND APPLICATION THEREOF | Apr 1, 2020 | Abandoned |
Array
(
[id] => 20328370
[patent_doc_number] => 12458627
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-04
[patent_title] => Autotaxin inhibitors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/821365
[patent_app_country] => US
[patent_app_date] => 2020-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 33906
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16821365
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/821365 | Autotaxin inhibitors and uses thereof | Mar 16, 2020 | Issued |
Array
(
[id] => 16087305
[patent_doc_number] => 20200197639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => Smokeless THC and Administration Method Thereof
[patent_app_type] => utility
[patent_app_number] => 16/786852
[patent_app_country] => US
[patent_app_date] => 2020-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16786852
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/786852 | Smokeless THC and Administration Method Thereof | Feb 9, 2020 | Abandoned |